Drug Maker, Execs Sued Over Alleged Involvement In Stock Pump-And-Dump Scheme

(March 19, 2021, 1:37 PM EDT) -- TACOMA, Wash. — A biotechnology company and two of its senior executives violated federal securities laws by misrepresenting to investors that its HIV-treatment drug could be used as a treatment for...
To view the full article, register now.